Coverage dated November 23, 2023

South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs

Headline from The Republic

CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.

The Republic's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

12 articles, oldest first.

  1. The Republic

    South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs (opens The Republic)

    Published

    The Republic's feed description

    CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.

  2. Green Field Reporter

    South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs - The Daily Reporter (opens Green Field Reporter)

    Published

    Green Field Reporter's feed description

    CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.

  3. Voice of America

    South Africa, Colombia Fighting Drugmakers Over Access to TB, HIV Drugs (opens Voice of America)

    Published

    Voice of America's feed description

    Some officials say the change was prompted by the vaccine inequity seen during COVID

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs | Since Then